TEVA

#330
Teva Pharmaceutical Industries Limited American Depositary Shar
35.3 3 USD
+2.29%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
34.64
35.45
Range Annuel
0.34
37.34
Changement quotidien
+2.29%
Changement Mensuel
-1.67%
Evolution sur 6 mois
+32.87%
Changement Annuel
+84.93%
Clôture Précédente
34.5 4
Open
34.6 5
Low
34.6 4
High
35.4 5
Volume
5 074
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

Nouvelles